The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) hosted at the University of Cambridge, with funding from The Mark Foundation for Cancer Research and the Cancer Research UK Cambridge Centre, aims to revolutionise cancer care by re-inventing the treatment pathway for patients.
You can find a full list of media coverage about MFICM on the News page
Patient represetatives Ann, Frankie and Lorainne engage in a lively discussion with ICM researchers Professor James Brenton and Drs Ines Machado and Gabriel Funingana on the use of AI in healthcare, hosted by Ellie Wolmark.
The test uses changes to cancer DNA at diagnosis to predict which patients will be resistant to three common types of chemotherapy. This new method could benefit thousands of patients every year by helping them avoid treatments that are less likely to benefit them.
Downing College and online, Tuesday 8th July 2025
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
